Vimarsana
Biggest News Aggregation in the World

Inform Diagnostic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inform Diagnostic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inform Diagnostic Today - Breaking & Trending Today

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call Transcript

Published: May 4, 2022

Fulgent Genetics, Inc. (NASDAQ:NASDAQ:FLGT) Q1 2022 Earnings Conference Call May 3, 2022, 04:30 PM ET Company Participants Nicole Borsje - IR Ming Hsieh - CEO Brandon Perthuis - Chief...

Source: seekingalpha.com
Related Topics:
United StatesEl MonteKevin DegeeterPaul KimNicole BorsjePiper SandlerLarry WeissBrandon PerthuisDavid WestenbergMing HsiehExchange CommissionCompany ParticipantsFulgent Genetics IncFulgent GeneticsConference Call MayGenetics Earnings ConferenceChief Executive OfficerChief Financial OfficerChief Medical OfficerChief CommercialInvestor RelationsAccounting Principles Generally AcceptedChief Commercial OfficerInform DiagnosticsSouthern California
Fulgent Agrees to Buy Texas Testing Firm Inform Diagnostics for $170M, boosting its non-Covid testing business. - Vimarsana News

Fulgent Agrees to Buy Texas Testing Firm Inform Diagnostics for $170M, boosting its non-Covid testing business.

Published: April 25, 2022

Learn more about Fulgent Genetics’ agreement to buy Texas testing firm Inform Diagnostics for $170 million, boosting its non-Covid testing business.

Source: labusinessjournal.com
Related Topics:
New YorkUnited StatesKevin DegeeterMing HsiehTemple Fulgent Genetics IncDiagnostics IncOppenheimer CoTemple City Based Fulgent GeneticsTexas Based Inform DiagnosticsAvista Capital PartnersNew York CityNew York Based OppenheimerLos Angeles CountyInform DiagnosticsInform DiagnosticInform Diagnostic CovidCovid Omicron